Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.9025
-0.0158 (-1.72%)
Oct 15, 2025, 3:20 PM EDT - Market open
Envoy Medical Revenue
Envoy Medical had revenue of $78.00K in the quarter ending June 30, 2025, with 14.71% growth. This brings the company's revenue in the last twelve months to $222.00K, down -26.49% year-over-year. In the year 2024, Envoy Medical had annual revenue of $225.00K, down -28.80%.
Revenue (ttm)
$222.00K
Revenue Growth
-26.49%
P/S Ratio
83.43
Revenue / Employee
$5,286
Employees
42
Market Cap
21.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 225.00K | -91.00K | -28.80% |
| Dec 31, 2023 | 316.00K | 79.00K | 33.33% |
| Dec 31, 2022 | 237.00K | -73.00K | -23.55% |
| Dec 31, 2021 | 310.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCOCH News
- 5 days ago - Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 7 days ago - Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 8 days ago - Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp
- 8 days ago - Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp
- 14 days ago - Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th - Newsfile Corp
- 20 days ago - Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 21 days ago - Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track - Newsfile Corp
- 23 days ago - Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp